Skip to main content
Clinical Trials/NCT04449315
NCT04449315
Completed
Not Applicable

Outpatient Oncology Aromatherapy

Central DuPage Hospital2 sites in 1 country40 target enrollmentStarted: October 10, 2020Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Central DuPage Hospital
Enrollment
40
Locations
2
Primary Endpoint
Post Intervention Interview From

Overview

Brief Summary

The purpose of this research study is to determine whether using aromatherapy during chemotherapy infusion treatments in the outpatient Oncology setting promote relief of nausea and anxiety.

The objectives of this study are: 1. To promote relief of nausea using peppermint aromatherapy oil in an outpatient oncology setting. 2. To promote relief of anxiety using lavender aromatherapy oil in an outpatient oncology setting.

Detailed Description

Subject Selection: Every outpatient oncology patient experiencing nausea and/or anxiety during an infusion visit will be offered hospital-approved aromatherapy of Peppermint oil or Lavender oil. If patient says yes, then they will be selected for the study and infusion nurse will notify the study co-investigators or principal investigator. Informed consent will then be obtained by co-investigators or principal investigator of the study. The consents as well as the data collection tool sheets will be numbered without identifying patient's personal information. Peppermint oil aromatherapy and/or lavender oil aromatherapy will then be administered to consented patients.

Method of Subject Identification and Recruitment: Every outpatient oncology patient experiencing nausea and/or anxiety during an infusion visit will be offered hospital- approved aromatherapy of Peppermint oil or Lavender oil. If patient says yes, then they will be selected for the study and infusion nurse will notify the study co-investigators or principal investigator. Informed consent will then be obtained by co-investigators or principal investigator of the study. The consents as well as the data collection tool sheets will be numbered without identifying patient's personal information. Peppermint oil aromatherapy and/or lavender oil aromatherapy will then be administered to consented patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All outpatient Oncology patients \> 18 years of age
  • Non pregnant
  • Not cognitively impaired
  • English speaking only
  • Patients who report nausea and/or anxiety

Exclusion Criteria

  • All outpatient oncology patients \<18 years of age
  • Cognitively impaired
  • Non-English Speaking
  • Patients who do not report nausea and/or anxiety
  • Patients with a known allergy to peppermint and/or lavender aromatherapy oil

Arms & Interventions

Peppermint and Lavender Essential Oil

Experimental

Young Living Essential oil of Peppermint and Lavender will be used to patients who meet the inclusion criteria.

Intervention: Young Living Lavender Essential Oil (Other)

Outcomes

Primary Outcomes

Post Intervention Interview From

Time Frame: Immediately upon Completion of the patient's infusion

After the patients' infusion they will be asked questions from this form

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Central DuPage Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials